Tepotinib
CAS 1100598-32-0Small Molecule
Overview
Tepotinib is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL3402762).
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Tepotinib expires 19 Mar 2030 and exclusivity 3 Feb 2028. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 3-[1-[[3-[5-[(1-methylpiperidin-4-yl)methoxy]pyrimidin-2-yl]phenyl]methyl]-6-oxopyridazin-3-yl]benzonitrile
- Canonical SMILES
- CN1CCC(CC1)COC2=CN=C(N=C2)C3=CC=CC(=C3)CN4C(=O)C=CC(=N4)C5=CC=CC(=C5)C#N
- InChIKey
- AHYMHWXQRWRBKT-UHFFFAOYSA-N
Verified Supplier Partner
Do you supply Tepotinib? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.